Self-righting systems and related components and methods

Patent metadata

Field	Value
Publication number	US-11607390-B2
Application number	US-201916691579-A
Country	US
Kind code	B2
Filing date	Nov 21, 2019
Priority date	May 17, 2017
Publication date	Mar 21, 2023
Grant date	Mar 21, 2023

Abstract

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface. The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage with a surface. In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject). In some cases, upon contact of the tissue with the tissue engaging surface of the article, the self-righting article may be configured to release one or more tissue interfacing components.

First claim

What is claimed is:

1. An ingestible self-righting article, comprising:
a self-actuating component;
a first compartment comprising a tissue interfacing component coupled to the self-actuating component; and
a fluidic gate associated with the first compartment, the fluidic gate configured to maintain the first compartment fluidically isolated from an external environment of the ingestible self-righting article until actuation of the self-actuating component;
wherein the self-righting article comprises a monostatic body due to at least one of the center of mass of the self-righting article and the shape of the self-righting article, such that the self-righting article has a single stable resting position.

2. The ingestible self-righting article of claim 1 , further comprising a second compartment, wherein the self-actuating component is positioned at least partially within the second compartment.

3. The ingestible self-righting article of claim 1 , wherein the fluidic gate is a barrier layer.

4. The ingestible self-righting article of claim 1 , wherein the fluidic gate is configured to be opened by the tissue interfacing component upon actuation of the self-actuating component.

5. The ingestible self-righting article of claim 1 , wherein the fluidic gate comprises a rupturable seal constructed and arranged to rupture when engaged by the tissue interfacing component during actuation of the self-actuating component.

6. The ingestible self-righting article of claim 1 , wherein the fluidic gate comprises one or more fluidically sealed apertures.

7. The ingestible self-righting article of claim 6 , wherein the one or more fluidically sealed apertures form self-sealing apertures.

8. The ingestible self-righting article of claim 1 , wherein the fluidic gate comprises a membrane.

9. The ingestible self-righting article of claim 8 , further comprising a first shell portion and a second shell portion, wherein the membrane is clamped between the first and second shell portions.

10. The ingestible self-righting article of claim 8 , wherein the fluidic gate comprises at least one weakened portion formed on the membrane.

11. The ingestible self-righting article of claim 10 , wherein the fluidic gate comprises a plurality of intersecting weakened portions formed on the membrane.

12. The ingestible self-righting article of claim 10 , wherein the membrane comprises a first portion having a first thickness and a second portion having a second thickness greater than the first thickness.

13. The ingestible self-righting article of claim 12 , wherein the membrane comprises one or more fluidically sealed apertures formed in the second portion.

14. The ingestible self-righting article of claim 8 , wherein the membrane is an elastic membrane, and wherein the elastic membrane is constructed and arranged to be under tension prior to actuation of the self-actuating component.

15. The ingestible self-righting article of claim 8 , further comprising one or more protrusions positioned within the first compartment, wherein the one or more protrusions are constructed and arranged to engage the membrane upon actuation of the self-actuating component.

16. The ingestible self-righting article of claim 15 , wherein the one or more protrusions are configured to puncture the membrane.

17. The ingestible self-righting article of claim 1 , wherein the membrane comprises one or more features constructed and arranged to propagate a crack in the membrane after actuation of the self-actuating component.

18. The ingestible self-righting article of claim 1 , further comprising an exit hole associated with the first compartment, wherein the fluidic gate comprises an elastic membrane covering the exit hole, the elastic membrane constructed and arranged to be engaged and opened by the tissue interfacing component upon actuation of the self-actuating component, and wherein the elastic membrane is constrained to deform only in portions of the elastic membrane overlying the exit hole.

19. The ingestible self-righting article of claim 1 , further comprising a tissue engaging surface defining an exit hole through which the tissue interfacing component is deployed upon actuation of the self-actuating component, wherein the fluidic gate comprises a membrane spaced from the exit hole and constructed and arranged to be opened by the tissue interfacing component upon actuation of the self-actuating component, and wherein the membrane is constrained such that the membrane does not extend out of the exit hole when opened by the tissue interfacing component.

20. The ingestible self-righting article of claim 1 , wherein the tissue interfacing component is spaced from the fluidic gate prior to actuation of the self-actuating component.

21. The ingestible self-righting article of claim 1 , wherein the fluidic gate is formed as a coating disposed on at least a portion of an external surface of the ingestible self-righting article.

22. The ingestible self-righting article of claim 1 , wherein the fluidic gate comprises silicone.

23. An ingestible self-righting article, comprising:
a self-actuating component;
a first compartment comprising a tissue interfacing component coupled to the self-actuating component; and
a fluidic gate associated with the first compartment, the fluidic gate comprising one or more fluidically sealed apertures;
wherein the ingestible self-righting article comprises a monostatic body due to at least one of the center of mass of the ingestible self-righting article and the shape of the ingestible self-righting article, such that the ingestible self-righting article has a single stable resting position.

24. The ingestible self-righting article of claim 23 , further comprising a second compartment, wherein the self-actuating component is positioned at least partially within the second compartment.

25. The ingestible self-righting article of claim 23 , wherein the fluidic gate is configured to be opened by the tissue interfacing component upon actuation of the self-actuating component.

26. The ingestible self-righting article of claim 23 , wherein the one or more fluidically sealed apertures form self-sealing apertures.

27. The ingestible self-righting article of claim 23 , wherein the fluidically sealed apertures include one or more thin cuts that extend completely through a thickness of the fluidic gate.

28. A method of administering a tissue interfacing component to a subject, comprising:
administering, to the subject, a self-righting article comprising the tissue interfacing component associated with a self-actuating component, wherein the tissue interfacing component is fluidically isolated from an external environment of the self-righting article by a fluidic gate; and wherein the self-righting article comprises a monostatic body due to at least one of the center of mass of the self-righting article and the shape of the ingestible self-righting article, such that the self-righting article has a single stable resting position; and
actuating the self-actuating component such that the tissue interfacing component actuates through the fluidic gate and penetrates a tissue located internal to the subject.

29. The method of claim 28 , wherein the fluidic gate is a barrier layer.

30. The method of claim 28 , wherein the fluidic gate comprises one or more fluidically s

Assignees

• Massachusetts Inst Technology
• Novo Nordisk As
• Brigham & Womens Hospital Inc

Inventors

• Abramson Alex G
• Frederiksen Morten Revsgaard
• Jensen Brian
• Jespersen Mikkel Oliver
• Traverso Carlo Giovanni

Classifications

• A61M2205/106

  reciprocating · CPC title

• A61K47/42

  Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34) · CPC title

• A61K47/10

  Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

• A61M2037/0007

  having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents · CPC title

• A61M37/00

  Other apparatus for introducing media into the body (for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30); Percutany, i.e. introducing medicines into the body by diffusion through the skin (salt baths A61H33/04) · CPC title